Negev Capital
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
80
organic / mo
Sign up free to see all 4 verified contacts at Negev Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- DS
Diаnа Sоfinа
Executive Assistant · General Business & Management
EmailPhone - AK
Alex Kubasov
Legal Counsel · Legal
EmailPhone - GD
Gennady Drushlyak
Chief Financial Officer · Finance & Accounting
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Negev Capital
4 distinct titles indexed · top 4 shown.
- 1chief financial officer
- 1executive assistant
- 1legal counsel
- 1partner
Sign up to unlock all 4 contacts at Negev Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Negev Capital
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.